Japan's challenges of translational regenerative medicine: Act on the safety of regenerative medicine
Author:
Publisher
Elsevier BV
Subject
Developmental Biology,Biomedical Engineering,Biomaterials
Reference5 articles.
1. Clinical trials in Japan;Fukushima;Nat Med,1995
2. New Japanese initiatives on stem cell therapies;Konomi;Cell Stem Cell,2015
3. New governmental regulatory system for stem cell-based therapies in Japan;Hara;Ther Innov Regul Sci,2014
4. Japan to offer fast-track approval path for stem cell therapies;Cyranoski;Nat Med,2013
5. World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects;World Medical Association;JAMA,2013
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Remote audit practice for inspection of structural and equipment standards for cell processing facilities under the act on the safety of regenerative medicine in Japan;Regenerative Therapy;2024-03
2. Attitudes towards human fetal tissue research: Survey of researchers and the public in Japan;Regenerative Therapy;2023-12
3. Current status of platelet-rich plasma therapy under the act on the safety of regenerative medicine in Japan;Regenerative Therapy;2023-06
4. Adipose-derived stem cells: Use in clinical medicine;Principles of Gender-Specific Medicine;2023
5. Unproven Stem Cell-Based Interventions: Addressing Patients’ Unmet Needs or Causing Patient Harms?;Philosophy and Medicine;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3